Archive for September, 2007

Progeniq joins Microsoft in Bio IT Alliance

September 26 : Microsoft Corp., announced the initiation of Progeniq Pte Ltd, a leader in reconfigurable computing applications headquartered in Singapore, into the BioIT

3rd World Congress for Regenerative Medicine in Leipzig

September 20, 2007 : Stem cells in today’s medical environment are seen as banners of hope in the treatment and prevention of incurable and chronic diseases.

IMAGNA project team started work on therapeutic vaccination against cat fibrosarcoma

September 20, 2007 : IMAGNA (immuno gene therapy with magnetic nanoparticles) has been founded by members of the Inst. of Experimental Oncology Klinikum rechts der Isar (Technical University Munich),

Drug Therapy Management Accreditation - New First-Ever Standards Just Released by URAC

Sept. 17 : For the first time, health plans, disease management, case management and pharmacy benefit management organizations can seek the seal of

MAF Currently Is Working to Cure Canine Cancer

Sept. 17 : Here is a unique, customized gift for the animal lover on your Christmas, Hanukah or other holiday list: a donation to the Morris Animal Foundation (MAF)

Pathway Diagnostics Announces Commercial Availability of SensiTrop HIV Co-receptor Tropism Assay

Sept. 17 : Pathway Diagnostics announces nationwide availability of SensiTrop(TM), its proprietary molecular heteroduplex tracking assay (HTA) for determining the co-receptor

United BioSource Acquires Caro Research, Leader in Simulation Modeling

Sept. 17 — United BioSource Corporation (UBC) today announced the acquisition of Caro Research, Inc., a leading provider of simulation technologies that help pharmaceutical and life

Enhanced Spellex Botanical dictionary now compatible with 2007 Microsoft Office

Sept 11 : Spellex Corporation announces the release of Spellex Botanical 2007, their popular botanical spelling software. The new release includes more than 50,000 specialty words from

Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the US Market

September 6, Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food